Amy Rabourn
Treasurer chez OCUPHIRE PHARMA, INC.
Fortune : 11 823 $ au 30/04/2024
Profil
Amy Rabourn is currently the Treasurer & Senior Vice President-Finance at Ocuphire Pharma, Inc. Prior to her current position, she worked as the Finance Director at Gemphire Therapeutics, Inc. from 2014 to 2019.
Ms. Rabourn has an undergraduate and graduate degree from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
0,03% | 15/04/2024 | 7 702 ( 0,03% ) | 11 823 $ | 30/04/2024 |
Postes actifs de Amy Rabourn
| Sociétés | Poste | Début |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - |
Anciens postes connus de Amy Rabourn
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/12/2019 |
Formation de Amy Rabourn
| University of Michigan | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
